Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

The bidirectional crosstalk between metastatic uveal melanoma cells and hepatic stellate cells engenders an inflammatory microenvironment.

Babchia N, Landreville S, Clément B, Coulouarn C, Mouriaux F.

Exp Eye Res. 2019 Feb 13. pii: S0014-4835(18)30840-6. doi: 10.1016/j.exer.2019.02.012. [Epub ahead of print]

PMID:
30771295
2.

Characterization of a tissue-engineered choroid.

Djigo AD, Bérubé J, Landreville S, Proulx S.

Acta Biomater. 2019 Jan 15;84:305-316. doi: 10.1016/j.actbio.2018.11.033. Epub 2018 Nov 23.

PMID:
30476582
3.

Regression rate of choroidal melanoma following iodine-125 brachytherapy is not associated with metastatic spread.

Pépin F, Julien AS, Fugaru I, Lihimdi N, Thariat J, Landreville S, Mouriaux F.

Melanoma Res. 2018 Oct 31. doi: 10.1097/CMR.0000000000000540. [Epub ahead of print]

PMID:
30383721
4.

Expression of the serotonin receptor 2B in uveal melanoma and effects of an antagonist on cell lines.

Weidmann C, Bérubé J, Piquet L, de la Fouchardière A, Landreville S.

Clin Exp Metastasis. 2018 Mar;35(3):123-134. doi: 10.1007/s10585-018-9894-x. Epub 2018 Apr 25.

PMID:
29696577
5.

Orbital recurrence of iris melanoma 21 years after enucleation.

Bergeron E, Lihimdi N, Bergeron D, Landreville S.

BMJ Case Rep. 2017 Sep 7;2017. pii: bcr-2017-221137. doi: 10.1136/bcr-2017-221137.

PMID:
28882848
6.

Differential responses of choroidal melanocytes and uveal melanoma cells to low oxygen conditions.

Weidmann C, Pomerleau J, Trudel-Vandal L, Landreville S.

Mol Vis. 2017 Mar 12;23:103-115. eCollection 2017.

7.

Effects of Long-term Serial Passaging on the Characteristics and Properties of Cell Lines Derived From Uveal Melanoma Primary Tumors.

Mouriaux F, Zaniolo K, Bergeron MA, Weidmann C, De La Fouchardière A, Fournier F, Droit A, Morcos MW, Landreville S, Guérin SL.

Invest Ophthalmol Vis Sci. 2016 Oct 1;57(13):5288-5301. doi: 10.1167/iovs.16-19317.

PMID:
27723895
8.

Contribution of Sp1 to Telomerase Expression and Activity in Skin Keratinocytes Cultured With a Feeder Layer.

Bisson F, Paquet C, Bourget JM, Zaniolo K, Rochette PJ, Landreville S, Damour O, Boudreau F, Auger FA, Guérin SL, Germain L.

J Cell Physiol. 2015 Feb;230(2):308-17. doi: 10.1002/jcp.24706.

PMID:
24962522
9.

Mechanisms of resistance to imatinib mesylate in KIT-positive metastatic uveal melanoma.

Calipel A, Landreville S, De La Fouchardière A, Mascarelli F, Rivoire M, Penel N, Mouriaux F.

Clin Exp Metastasis. 2014 Jun;31(5):553-64. doi: 10.1007/s10585-014-9649-2. Epub 2014 Mar 21.

PMID:
24652072
10.

Increased HIF-1α expression correlates with cell proliferation and vascular markers CD31 and VEGF-A in uveal melanoma.

Mouriaux F, Sanschagrin F, Diorio C, Landreville S, Comoz F, Petit E, Bernaudin M, Rousseau AP, Bergeron D, Morcos M.

Invest Ophthalmol Vis Sci. 2014 Mar 4;55(3):1277-83. doi: 10.1167/iovs.13-13345.

PMID:
24481264
11.

Retinoblastoma protein prevents enteric nervous system defects and intestinal pseudo-obstruction.

Fu M, Landreville S, Agapova OA, Wiley LA, Shoykhet M, Harbour JW, Heuckeroth RO.

J Clin Invest. 2013 Dec;123(12):5152-64. doi: 10.1172/JCI67653. Epub 2013 Nov 1.

12.

Repression of genes involved in melanocyte differentiation in uveal melanoma.

Bergeron MA, Champagne S, Gaudreault M, Deschambeault A, Landreville S.

Mol Vis. 2012;18:1813-22. Epub 2012 Jul 4.

13.

Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.

Landreville S, Agapova OA, Matatall KA, Kneass ZT, Onken MD, Lee RS, Bowcock AM, Harbour JW.

Clin Cancer Res. 2012 Jan 15;18(2):408-16. doi: 10.1158/1078-0432.CCR-11-0946. Epub 2011 Oct 28.

14.

Identification of differentially expressed genes in uveal melanoma using suppressive subtractive hybridization.

Landreville S, Lupien CB, Vigneault F, Gaudreault M, Mathieu M, Rousseau AP, Guérin SL, Salesse C.

Mol Vis. 2011;17:1324-33. Epub 2011 May 13.

15.

Suppression of α5 gene expression is closely related to the tumorigenic properties of uveal melanoma cell lines.

Landreville S, Vigneault F, Bergeron MA, Leclerc S, Gaudreault M, Morcos M, Mouriaux F, Salesse C, Guérin SL.

Pigment Cell Melanoma Res. 2011 Aug;24(4):643-55. doi: 10.1111/j.1755-148X.2011.00869.x. Epub 2011 Jun 15.

PMID:
21592318
16.

ABCB1 identifies a subpopulation of uveal melanoma cells with high metastatic propensity.

Landreville S, Agapova OA, Kneass ZT, Salesse C, Harbour JW.

Pigment Cell Melanoma Res. 2011 Jun;24(3):430-7. doi: 10.1111/j.1755-148X.2011.00841.x. Epub 2011 Mar 24.

17.

Loss of Id2 potentiates the tumorigenic effect of Rb inactivation in a mouse model of retinoblastoma.

Landreville S, Ma D, Wu J, Harbour JW.

Curr Eye Res. 2010 May;35(5):435-9. doi: 10.3109/02713680903509428.

18.

Emerging insights into the molecular pathogenesis of uveal melanoma.

Landreville S, Agapova OA, Harbour JW.

Future Oncol. 2008 Oct;4(5):629-36. doi: 10.2217/14796694.4.5.629. Review.

19.

Comparison between the gene expression profile of human Müller cells and two spontaneous Müller cell lines.

Lupien CB, Bolduc C, Landreville S, Salesse C.

Invest Ophthalmol Vis Sci. 2007 Nov;48(11):5229-42.

PMID:
17962478
20.

Expression of phospholipases A2 and C in human corneal epithelial cells.

Landreville S, Coulombe S, Carrier P, Gelb MH, Guérin SL, Salesse C.

Invest Ophthalmol Vis Sci. 2004 Nov;45(11):3997-4003.

Supplemental Content

Loading ...
Support Center